ConductScience.org, home

Paper354397

Clinical trial comparing timolol ophthalmic solution to pilocarpine in open-angle glaucoma.

Boger WP and 3 others. Am J Ophthalmol, 1978. Cited by 94 papers, by iCite.

Cite this record

ConductScience Library. Clinical trial comparing timolol ophthalmic solution to pilocarpine in open-angle glaucoma. Papers, record 354397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/354397

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical trial comparing timolol ophthalmic solution to pilocarpine in open-angle glaucoma.
PubMed
Journal
Am J Ophthalmol
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
94
iCite
Relative citation ratio, by iCite
6.86
iCite
Revised in PubMed
2019-06-27
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Boger WP 3rdW P
2Steinert RFR F
3Puliafito CAC A
4Pavan-Langston DD

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlaucomaMajor topic
PilocarpineMajor topic
PropanolaminesMajor topic
TimololMajor topic
Adult
Aged
Blood Pressure
Clinical Trials as Topic
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Intraocular Pressure
Male
Middle Aged
Ophthalmic Solutions
Pulse

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.

PMIDTitleJournalYearIn PapersSource
42970148The risk of rhegmatogenous retinal detachment associated with topical pilocarpine: a systematic review.Int Ophthalmol2026https://conductscience.org/library/papers/42970148PubMed
36246939Combinations of Pilocarpine and Oxymetazoline for the Pharmacological Treatment of Presbyopia: Two Randomized Phase 2 Studies.Ophthalmol Sci2021https://conductscience.org/library/papers/36246939PubMed
35235173In Vitro and In-Eye Comparison of Commercial Pilocarpine Ophthalmic Solution and an Optimized, Reformulated Pilocarpine for Presbyopia Treatment.Ophthalmol Ther2022https://conductscience.org/library/papers/35235173PubMed
33237496Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events.Am J Clin Dermatol2021https://conductscience.org/library/papers/33237496PubMed
31191995Timolol 0.1% in Glaucomatous Patients: Efficacy, Tolerance, and Quality of Life.J Ophthalmol2019https://conductscience.org/library/papers/31191995PubMed
30794789Effect of Timolol on Aqueous Humor Outflow Facility in Healthy Human Eyes.Am J Ophthalmol2019https://conductscience.org/library/papers/30794789PubMed
14660460Intraocular pressure after replacement of current dual therapy with latanoprost monotherapy in patients with open angle glaucoma.Br J Ophthalmol2003https://conductscience.org/library/papers/14660460PubMed
8981691Ocular hypotensive efficacy and safety of a combined formulation of betaxolol and pilocarpine.Trans Am Ophthalmol Soc1996https://conductscience.org/library/papers/8981691PubMed
7398530Timolol eye drops: bradycardia or tachycardia?Doc Ophthalmol1980https://conductscience.org/library/papers/7398530PubMed
7363532Absorption of ocular timolol.Clin Pharmacokinet1980https://conductscience.org/library/papers/7363532PubMed
7363024The Flowers report: a personal view.Br Med J1980https://conductscience.org/library/papers/7363024PubMed
7028085Study of the additive effect of timolol and epinephrine in lowering intraocular pressure.Br J Ophthalmol1981https://conductscience.org/library/papers/7028085PubMed
7004479Interaction of timolol and adrenaline.Br J Ophthalmol1981https://conductscience.org/library/papers/7004479PubMed
6123368Beta-blockers in the treatment of chronic simple glaucoma.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6123368PubMed
6118072Penetration of five beta-adrenergic antagonists into the rabbit eye after ocular instillation.Albrecht Von Graefes Arch Klin Exp Ophthalmol1981https://conductscience.org/library/papers/6118072PubMed
2411566Effect of ophthalmic administration of S-596 (Arotinolol) on intraocular pressure and haemodynamics in health volunteers: comparison with timolol.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/2411566PubMed
526463Management of acute closed-angle glaucoma with miotics and timolol.Br J Ophthalmol1979https://conductscience.org/library/papers/526463PubMed
369807Timolol: a review of its therapeutic efficacy in the topical treatment of glaucoma.Drugs1979https://conductscience.org/library/papers/369807PubMed
38956The treatment of glaucoma: role of beta-blocking agents.Drugs1979https://conductscience.org/library/papers/38956PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/354397

GET https://conductscience.org/api/papers/v1/354397/authors